Page 7 - Read Online
P. 7

29         Efficacy and HCC development after DAA therapy for patients with chronic hepatitis C: a single
                            center retrospective cohort study
                            Akitoshi Douhara, Hiroyuki Ogawa, Satoshi Nakatani, Takahiro Ozutsumi, Erika Shioyama, Masaaki
                            Yoshikawa, Shigehiko Ueda
                            Hepatoma Res 2017;3:215-220  http://dx.doi.org/10.20517/2394-5079.2017.32


               30         Interventional radiology for post-transplant anastomotic complications
                            Toshiya Shibata
                            Hepatoma Res 2017;3:221-227  http://dx.doi.org/10.20517/2394-5079.2017.34


               31         Reducing liver cancer risk beginning at birth: experiences of preventing chronic hepatitis B virus
                            infection in China
                            Chunfeng Qu, Zhongping Duan, Kun Chen, Huaibin Zou
                            Hepatoma Res 2017;3:228-240  http://dx.doi.org/10.20517/2394-5079.2017.41


               32         Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced
                            carcinogenesis
                            Guang-Wen Cao
                            Hepatoma Res 2017;3:241-259  http://dx.doi.org/10.20517/2394-5079.2017.45

               33         Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in
                            sorafenib treatment for hepatocellular carcinoma
                            Michele Lecchini, Andrea Olivani, Elisabetta Biasini, Raffaele Dalla Valle, Carlo Ferrari, Gabriele
                            Missale, Claudia Schianchi
                            Hepatoma Res 2017;3:260-267  http://dx.doi.org/10.20517/2394-5079.2017.44

               34         Role of early growth response 1 in liver metabolism and liver cancer
                            Nancy Magee, Yuxia Zhang
                            Hepatoma Res 2017;3:268-277  http://dx.doi.org/10.20517/2394-5079.2017.36


               35         Robotic hepatectomy for hepatocellular carcinoma: a clinical review
                            Eric C.H. Lai, Daniel T.M. Chung, Oliver C.Y. Chan, Chung Ngai Tang
                            Hepatoma Res 2017;3:278-283  http://dx.doi.org/10.20517/2394-5079.2017.37


               36         The role of oral antiviral therapy in hepatitis B-related hepatocellular carcinoma
                            James Fung, Kenneth S.H. Chok
                            Hepatoma Res 2017;3:284-293  http://dx.doi.org/10.20517/2394-5079.2017.38

               37         Association of serum levels of transforming growth factor βwith disease severity in patients with
                            hepatocellular carcinoma
                            Mohamed Ahmed Samy Kohla, Ahmed Attia, Nehad Darwesh, Manar Obada, Hossam Taha, Marwa F.
                            Youssef
                            Hepatoma Res 2017;3:294-301  http://dx.doi.org/10.20517/2394-5079.2017.40
   2   3   4   5   6   7   8   9   10   11   12